ConductScience.org, home

Paper3894793

Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.

Sibley RK and 3 others. Lab Invest, 1985. Cited by 387 papers, by iCite.

Cite this record

ConductScience Library. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Papers, record 3894793. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3894793

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.
PubMed
Journal
Lab Invest
PubMed
Year
1985
PubMed
Publication types
Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
387
iCite
Relative citation ratio, by iCite
9.14
iCite
Revised in PubMed
2007-11-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sibley RKR K
2Sutherland DED E
3Goetz FF
4Michael AFA F

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 1Major topic
Pancreas TransplantationMajor topic
Adult
Antibodies, Monoclonal
Diseases in Twins
Female
HLA-DR Antigens
Histocompatibility Antigens Class II
Humans
Immunity, Cellular
Immunochemistry
Islets of Langerhans
Microscopy, Electron
Pancreas
Recurrence
Transplantation, Homologous
Transplantation, Isogeneic

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI 10704NIAID NIH HHSUnited StatesR01AI010704PubMed and NIHNIH RePORTER
AM 13083NIADDK NIH HHSUnited StatesP01AM013083PubMed and NIHNIH RePORTER
AM 25518NIADDK NIH HHSUnited StatesR01AM025518PubMed and NIHNIH RePORTER
P02AM013083NIHNIH RePORTER
R37AI010704NIHNIH RePORTER

Download CSV of grants

Cited by103

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 387 citations.

PMIDTitleJournalYearIn PapersSource
39658052Lymph nodes as gatekeepers of autoimmune diseases.RMD Open2024https://conductscience.org/library/papers/39658052PubMed
39346923Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation.Front Immunol2024https://conductscience.org/library/papers/39346923PubMed
36545154Genetic Engineering of Immune Evasive Stem Cell-Derived Islets.Transpl Int2022https://conductscience.org/library/papers/36545154PubMed
35418988The Influence of Microenvironment on Survival of Intraportal Transplanted Islets.Front Immunol2022https://conductscience.org/library/papers/35418988PubMed
35163121
Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes.
Int J Mol Sci2022https://conductscience.org/library/papers/35163121PubMed
34102338Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.Acta Biomater2021https://conductscience.org/library/papers/34102338PubMed
34067829
Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes.
Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34067829PubMed
33918805Islet Dysfunction in a Novel Transgenic Model of T Cell Insulitis.Biomolecules2021https://conductscience.org/library/papers/33918805PubMed
33293704Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).Nat Rev Endocrinol2021https://conductscience.org/library/papers/33293704PubMed
32668238Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells.Cell Rep2020https://conductscience.org/library/papers/32668238PubMed
31767825Autoimmune Diabetes Recurrence After Pancreas Transplantation: Diagnosis, Management, and Literature Review.Ann Transplant2019https://conductscience.org/library/papers/31767825PubMed
30541144Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.Endocr Rev2019https://conductscience.org/library/papers/30541144PubMed
29196783Combinatorial detection of autoreactive CD8+ T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell Workshop.Diabetologia2018https://conductscience.org/library/papers/29196783PubMed
28864875Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".Curr Diab Rep2017https://conductscience.org/library/papers/28864875PubMed
28099204Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'.Curr Opin Endocrinol Diabetes Obes2017https://conductscience.org/library/papers/28099204PubMed
27798614Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.Nat Med2016https://conductscience.org/library/papers/27798614PubMed
27348473Biomarkers in pancreas transplant.Curr Opin Organ Transplant2016https://conductscience.org/library/papers/27348473PubMed
27110598Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?Immunotherapy (Los Angel)2015https://conductscience.org/library/papers/27110598PubMed
27063289A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells.Nat Commun2016https://conductscience.org/library/papers/27063289PubMed
26970668Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.Transplant Rev (Orlando)2016https://conductscience.org/library/papers/26970668PubMed

See all 103 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD2914PubTator's text mininghttps://conductscience.org/library/genes/914NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
TFRC7037PubTator's text mininghttps://conductscience.org/library/genes/7037NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3894793

GET https://conductscience.org/api/papers/v1/3894793/cited_by?page=2